| |
Selected Publications
Selected from over 200 publications
The following recent studies were conducted
in Dr. Israel's laboratory by postdoctoral fellows and students
working under his direct, daily supervision. The projects were
conceived by Dr. Israel and the experimental strategies refined in
association with the fellows and students.

Tada T, Nguyen JB, Hitoshi Y, Watson NP, Dunn JF, Ohara S, Nagano S, Kosai K, Israel MA.
Diffuse encephaloventriculitis and substantial leukoencephalopathy after intraventricular administration of recombinant adenovirus.
Neurol Res. 2005 Jun;27(4):378-86.
Liang Y, Diehn M, Watson N, Bollen AW, Adlape KD, Nicholas MK, Lamborn
KR, Berger MS, Botstein D, Brown PO, Israel MA. Gene expression profiling reveals molecularly and clinically distinct subtypes of
glioblastomas multiforme. PNAS 2005
Apr 19;102(16):5814-9. Epub 2005 Apr 12. (PDF file)
Yun K, Mantani A, Garel S, Rubenstein J, Israel MA. Id4 regulates neural progenitor proliferation and differentiation in vivo. Development. 2004 Nov;131(21):5441-8. Epub 2004 Oct 06.(PDF file)
Murphy DJ, Swigart LB, Israel MA, Evan GI.
Id2 is dispensable for Myc-induced epidermal neoplasia.
Mol Cell Biol. 2004 Mar;24(5):2083-90. (PDF file)
Weiss WA, Burns MJ, Hackett C, Aldape K, Hill JR, Kuriyama H, Kuriyama N, Milshteyn N, Roberts T, Wendland MF, DePinho R, Israel MA.Genetic determinants of malignancy in a mouse model for oligodendroglioma.Cancer Res. 2003 Apr 1;63(7):1589-95. (PDF file)
Houghton PJ, Adamson PC, Blaney S, Fine HA, Gorlick R, Haber M, Helman L, Hirschfeld S, Hollingshead MG, Israel MA, Lock RB, Maris JM, Merlino G, Patterson W, Reynolds CP, Shannon K, Yu A, Yu J, Smith MA.Testing of new agents in childhood cancer preclinical models: meeting summary. Clin Cancer Res. 2002 Dec;8(12):3646-57.
Tsuyoshi
Tada, Mike Wendland, Nathan Watson, Nagato Kuriyama, Hiroko Kuriyama,
Tim Roberts, Michael Burns, William Weiss, Mark A. Israel. A head
holder for magnetic resonance imaging that allows the stereotaxic
alignment of spontaneously occurring intracranial mouse tumors.
Journal of Neuroscience Methods 116 (2002). (PDF
file)
Nathalie
A. Lokker, Carol M. Sullivan, Stanley J. Hollenbach, Mark A. Israel,
and Neill A. Giese. Platelet-derived Growth Factor (PDGF) Autocrine
Signaling Regulates Survival and Mitogenic Pathways in Glioblastoma
Cells: Evidence That the Novel PDGF-C and PDGF-D Ligands May Play
a Role in the Development of Brain Tumors. CANCER RESEARCH 62, 3729–3735,
July 1, 2002. (PDF file)
Martha L. Simmons, Kathleen R. Lamborn, Michelle Takahashi, Pengchin
Chen, Mark A. Israel, Mitchel S. Berger, Tony Godfrey, Janice Nigro,
Michael Prados, Susan Chang, Fred G. Barker II, and Ken Aldape.
Analysis of Complex Relationships between Age, p53, Epidermal Growth
Factor Receptor, and Survival in Glioblastoma Patients. CANCER RESEARCH
61, 11221128, February 1, 2001. (PDF file)
David
S. Rickman, Rachana Tyagi, Xiao-Xiang Zhu, Miroslav P. Bobek, Suzan
Song, Mila Blaivas, David E. Misek, Mark A. Israel, David M. Kurnit,
Donald A. Ross, Phillip E. Kish, and Samir M. Hanash. The Gene for
the Axonal Cell Adhesion Molecule TAX-1 Is Amplified and Aberrantly
Expressed in Malignant Gliomas. CANCER RESEARCH 61, 21622168, March
1, 2001. (PDF file)
Nagato Kuriyama, Hiroko Kuriyama, Carol M. Julin, Kathleen R. Lamborn,
and Mark A. Israel. Protease Pretreatment Increases the Efficacy
of Adenovirus-mediated Gene Therapy forthe Treatment of an Experimental
Glioblastoma Model. CANCER RESEARCH 61, 18051809, March 1, 2001.
(PDF file)
Kuriyama N, Kuriyama H, Julin CM, Lamborn K, Israel MA. Pre-treatment with protease is a useful experimental strategy for enhancing adenovirus mediated cancer gene therapy. Human Gene Therapy. Hum Gene Ther. 2000 Nov 1;11(16):2219-30.
Carola
H. Biederer, Stefan J. Ries, Markus Moseri, Monica Florio, Mark
A. Israel, Frank McCormick, and Reinhard Buettner. The Basic Helix-Loop-Helix
Transcription Factors Myogenin and Id2 Mediate Specific Induction
of Caveolin-3 Gene Expression during Embryonic Development. THE
JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 275, No. 34, Issue of August
25, 2000. (PDF file)
Mary
J. Janatpour1, Michael T. McMaster, Olga Genbacev, Yan Zhou, Jian-Yun
Dong, James C. Cross, Mark A. Israel, and Susan J. Fisher. Id-2
regulates critical aspects of human cytotrophoblast differentiation,
invasion and migration. Development 127, 549-558 (2000). (PDF
file)
Haas-Kogan
DA, Kogan SS, Yount G, Hsu J, Haas M, Deen DF, Israel MA. P53 function
influences the effect of fractionated radiotherapy on glioblastoma
tumors, Intl J Radiat Oncol Biol Phys, 43:399-403, 1999.(PDF
file)
Haruhisa
Maruyama, Jorg Kleeff, Stefan Wildi, Helmut Friess, Markus W. Buchler,
Mark A. Israel, and Murray Korc. Id-1 and Id-2 Are Overexpressed
in Pancreatic Cancer and in Dysplastic Lesions in Chronic Pancreatitis.
American Journal of Pathology, Vol. 155, No. 3, September 1999.
(PDF file)
RHODA
M. ALANI, JENS HASSKARL, MIRANDA GRACE, MARIA-CLEMENTIA HERNANDEZ,
MARK A. ISRAEL, AND KARL MU NGER. Immortalization of primary human
keratinocytes by the helixloophelix protein, Id-1. Proc. Natl.
Acad. Sci. USA Vol. 96, pp. 96379641, August 1999. (PDF
file)
DAPHNE
A. HAAS-KOGAN, M.D., SCOTT S. KOGAN, M.D., GARRET YOUNT, PH.D.,
JENNIE HSU, MARTIN HAAS, M.D., DENNIS F. DEEN, PH.D., AND MARK A.
ISRAEL, M.D. P53 FUNCTION INFLUENCES THE EFFECT OF FRACTIONATED
RADIOTHERAPY ON GLIOBLASTOMA TUMORS. Int. J. Radiation Oncology
Biol. Phys., Vol. 43, No. 2, pp. 399403, 1999. (PDF
file)
Pedro
J. Andres-Barquin, Maria-Clemencia Hernandez, and Mark A. Israel.
Id4 Expression Induces Apoptosis in Astrocytic Cultures and Is Down-regulated
by Activation of the cAMP-Dependent Signal Transduction Pathway.
Experimental Cell Research 247, 347355 (1999). (PDF
file)
Florio
M, Hernandez M-C, Yang H, Shu H-K, Cleveland JL, Israel MA. Id2
promotes apoptosis by a novel mechanism independent of dimerization
of basic helix-loop-helix factors, Mol Cell Biol 18:5435-5444, 1998.(PDF
file)
HUI-KUO
G. SHU, MOSES M. KIM, PENGCHIN CHEN, FELIX FURMAN, CAROL M. JULIN,
AND MARK A. ISRAEL. The intrinsic radioresistance of glioblastoma-derived
cell lines is associated with a failure of p53 to induce p21BAX
expression. Proc. Natl. Acad. Sci. USA Vol. 95, pp. 1445314458,
November 1998. (PDF file)
MONICA
FLORIO, MARIA-CLEMENCIA HERNANDEZ, HUI YANG, HUI-KUO SHU, JOHN L.
CLEVELAND AND MARK A. ISRAEL. Id2 Promotes Apoptosis by a Novel
Mechanism Independent of Dimerization to Basic Helix-Loop-Helix
Factors. MOLECULAR AND CELLULAR BIOLOGY, Sept. 1998. (PDF
file)
Lee
J. Helman, Thomas G. Ahng, Michael A. Levineg, Audrey Allison, Pamela
S . Cohen, Mark J. Cooper, David V. Cohnll, and Mark A. Israel.
Molecular Cloning and Primary Structure of Human Chromogranin A
(Secretory Protein I) cDNA. THE JOURNAL OF BIOLOGICAL CHEMISTRY
Vol. 263, No. 23, Issue of August 15, pp. 11559-11563,1988 (PDF
file)
Shu
H-KG, Kim MM, Furman F, Julin CM, Israel MA. The intrinsic radioresistance
of glioblastoma-derived cell lines is associated with a failure
of p53 to induce p21BAX expression, Proc Natl Acad Sci USA 95:14453-14458,
1998.(PDF file)
Akio
Mantani, Maria-Clemencia Hernandez, Wen-Lin Kuo, Mark A. Israel.
The mouse Id2 and Id4 genes: structural organization and chromosomal
localization. Gene 222 (1998). (PDF file)
Maria-Clemencia
Hernandez, Pedro J. Andres-Barquin, Salvador Martinez, Alexandro
Bulfone, John L.R. Rubenstein, and Mark A. Israel. ENC-1: A Novel
Mammalian Kelch-Related Gene Specifically Expressed in the Nervous
System Encodes an Actin-Binding Protein. The Journal of Neuroscience,
May 1, 1997, 17(9):30383051. (PDF file)
Hernandez
M-C, Andres-Barquin PJ, Martinez S, Bulfone A, Rubenstein JLR, Israel
MA. ENC-1: A novel mammalian kelch-related gene specifically expressed
in the nervous system encodes an actin-binding protein, J Neurosci
17:3038-3051, 1997.(PDF file)
A. LASORELLA, A. IAVARONE, AND M. A. ISRAEL. Id2 Specifically Alters
Regulation of the Cell Cycle by Tumor Suppressor Proteins. MOLECULAR
AND CELLULAR BIOLOGY, June 1996. (PDF file)
Lasorella
A, Iavarone A, Israel MA. Id-2 specifically alters the regulation
of the cell cycle by tumor suppressor proteins, Mol Cell Biol 16:2570-2578,
1996.(PDF file)
James
Fick, Fred G. Barker II, Paul Dazin, Eileen M. Westphale, Eric C.
Beyer, and Mark A. Israel. The extent of heterocellular communication
mediated by gap junctions is predictive of bystander tumor cytotoxicity
in vitro. Proc. Natl. Acad. Sci. USA. Vol. 92, pp. 11071-11075, November
1995. (PDF file)
Joseph
Biggs, Elizabeth V. Murphy, and Mark A. Israel. A human Id-like
helix-loop-helix protein expressed during early development. Proc.
Natl. Acad. Sci. USA, Vol. 89, February 1992 (PDF
file)
Jeffrey
M. Friedman, Maria Vitale, Jonathan Maimon, Mark A. Israel, Marc
E. Horowitz, and Bruce S. Schneider. Expression of the cholecystokinin
gene in pediatric tumors. Proc. Natl. Acad. Sci., Vol. 89, July
1992. (PDF file)
Antonio
Iavarone, Katherine K. Matthay, Terri M. Steinkirchner, and Mark
A. Israel. Germ-line and somatic p53 gene mutations in multifocal
osteogenic sarcoma. Proc. Natl. Acad. Sci., Vol. 89, May 1992. (PDF
file)
Neal
Rose, Joseph B. BolenlIII , Arnold M. Schwartz, Pam CohenS, Virginia
DeSeaun, and Mark A. Israel. Analysis of pp60c-s'c Protein Kinase
Activity in Human Tumor Cell Lines and Tissues. THE JOURNAL OF BIOLOGICAL
CHEMISTRY Vol. 261, No. 29, Issue of October 15, 1986 (PDF
file)
Joseph
B. Bolen and Mark A. Israel. In Vitro Association and Phosphorylation
of Polyoma Virus Middle T Antigen by Cellular Tyrosyl Kinase Activity.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 269, No. 19. Issue of October
10, 1984 (PDF file)
Joseph
B. Bolen and Mark A. Israel. Inhibition of Polyoma Virus Middle T
Antigen-associated Tyrosyl Kinase Activity by N-Ethylmaleimide." THE
JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 258, No. 24, Issue of December
25, 1983. (PDF file)
Mark
A. Israel, David F. Vanderryn, Marcia L. Meltzer, and Malcolm A.
Martin. Characterization of Polyoma Viral DNA Sequences in Polyoma-induced
Hamster Tumor Cell Lines. THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol.
255, No. 8, Issue of April 25, 1980 (PDF file)
|